Θα παραμείνει ανοικτή και θα δέχεται νέες αιτήσεις έως την 11η Μαρτίου
Lavipharm: Focus on the development, production and sale of pharmaceutical products
Lavipharm’s financial figures were presented by the Group’s CFO Vasilis Baloumis, during the annual analyst briefing at the Athens Stock Exchange. The figures reflect dynamic